It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and regulatory updates were in focus. Recap of the Week’s ...
Zacks.com on MSN4h
Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDAIt was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...
Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corporation (SCHW), ...
Hosted on MSN22h
Gilead’s lenacapavir applications for HIV gain EMA validationGilead Sciences has announced the European Medicines Agency’s (EMA) validation for a parallel accelerated review of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback